MedPath

The effects of palmitate and chicoric acid on diabetes

Not Applicable
Recruiting
Conditions
Diabetes.
Non-insulin-dependent diabetes mellitus
Registration Number
IRCT2017071535085N1
Lead Sponsor
Hamadan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

FBS greater than 126 mg/dL; 2 hours blood glucose greater than 200 mg/dl; HbA1C greater than 6.5%; The control group should have a fasting blood glucose less than 100 mg/dl.

Exclusion criteria:
Use of medications such as antihypertensive drugs (such as beta-blockers), anti-diabetic drugs, estrogen supplements, thyroxine, diuretics and hypolipemic drugs; Other chronic and acute inflammatory diseases such as chronic kidney disease, cardiovascular disease, hypertension and ...; Infectious diseases, cancer, allergies; Other Endocrine Disorders (Except Type 2 Diabetes); Pregnancy; Smoking

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
SIRT1. Timepoint: One day after the intervention, Two day after the intervention. Method of measurement: Gene expression of SIRT1 using Ct of gene.;IL-6. Timepoint: One day after the intervention, Two day after the intervention. Method of measurement: Gene expression of IL-6 using Ct of gene.;P-AMPK. Timepoint: One day after the intervention, Two day after the intervention. Method of measurement: concentration of p-AMPK using western blotting.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath